SHORT COMMUNICATION
Production of an active human AID enzyme in a bacterial system
 
More details
Hide details
1
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland
 
2
Institute of Computing Science, Poznan University of Technology, Poznań, Poland
 
 
Publication date: 2016-11-02
 
 
BioTechnologia 2016;97(3):235-239
 
ABSTRACT
The aim of our invention is to characterize a modified gene of human activation-induced cytidine deaminase (hAID ), a method of modification of hAID gene, a composition showing hAID activity, and a method of preparation of such composition in a bacterial system. In particular, the invention concerns a modified hAID gene for the production of an active enzyme in a bacterial system as well as use of such composition for the analyzes of DNA/RNA amination/deamination, and/or methylation/demethylation.
REFERENCES (20)
1.
Beale R.C., Petersen-Mahrt S.K., Watt I.N., Harris R.S., Rada C., Neuberger M.S. (2004) Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J. Mol. Biol. 337: 585-596.
 
2.
Bestor T.H. (2000) The DNA methyltransferases of mammals. Hum. Mol. Genet. 9: 2395-2402.
 
3.
Bransteitter R., Pham P., Calabrese P., Goodman M.F. (2004) Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase. J. Biol. Chem. 279: 51612-51621.
 
4.
Conticello S.G. (2008) The AID/APOBEC family of nucleic acid mutators. Genome Biol. 9: 229.
 
5.
Crouch E.E., Li Z., Takizawa M., Fichtner-Feigl S., Gourzi P., Montano C., Feigenbaum L., Wilson P., Janz S., Papavasiliou F. N., et al. (2007) Regulation of AID expression in the immune response. J. Exp. Med. 204: 1145-1156.
 
6.
Delker R.K., Fugmann S.D., Papavasiliou F.N. (2009) A coming- of-age story: activation-induced cytidine deaminase turns 10. Nat. Immunol. 10: 1147-1153.
 
7.
Dickerson S.K., Market E., Besmer E., Papavasiliou F.N. (2003) AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197: 1291-1296.
 
8.
Epeldegui M., Hung Y.P., Mcquay A., Ambinder R.F., Martinez- Maza O. (2007) Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol. Immunol. 44: 934-942.
 
9.
Gehring M., Reik W., Henikoff S. (2009) DNA demethylation by DNA repair. Trends Genet. 25: 82-90.
 
10.
Holden L.G., Prochnow C., Chang Y.P., Bransteitter R., Chelico L., Sen U., Stevens R.C., Goodman M.F., Chen X.S. (2008) Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications. Nature 456: 121-124.
 
11.
Machida K., Kondo Y., Huang J.Y., Chen Y.C., Cheng K.T., Keck Z., Foung S., Dubuisson J., Sung V.M., Lai M.M. (2008) Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein. J. Virol. 82: 6711-6720.
 
12.
Marusawa H. (2008) Aberrant AID expression and human cancer development. Int. J. Biochem. Cell Biol. 40: 1399-1402.
 
13.
Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
 
14.
Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., Honjo T. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274: 18470-18476.
 
15.
Papavasiliou F.N., Schatz D.G. (2002) The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process. J. Exp. Med. 195: 1193-1198.
 
16.
Prochnow C., Bransteitter R., Klein M.G., Goodman M.F., Chen X.S. (2007) The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature 445: 447-451.
 
17.
Ramiro A.R., Barreto V.M. (2015) Activation-induced cytidine deaminase and active cytidine demethylation. Trends Biochem. Sci. 40: 172-181.
 
18.
Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., et al. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
 
19.
Samaranayake M., Bujnicki J.M., Carpenter M., Bhagwat A.S. (2006) Evaluation of molecular models for the affinity maturation of antibodies: roles of cytosine deamination by AID and DNA repair. Chem. Rev. 106: 700-719.
 
20.
Shivarov V., Shinkura R., Honjo T. (2008) Dissociation of in vitro DNA deamination activity and physiological functions of AID mutants. Proc. Natl. Acad. Sci. USA 105: 15866-15871.
 
eISSN:2353-9461
ISSN:0860-7796
Journals System - logo
Scroll to top